Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
Key Information
Due Date: December 23, 2027
Agency: United States Department of Health and Human Services
Source: Federal
Funding Categories:
Funding Amount: Not Specified
Funding Type: Grant
Match Required: No
Status: Posted
NIH Grants Information grantsinfo@nih.gov
Overview
needed for the activities required to identify and characterize potential therapeutic candidates and combination products to treat HLBS diseases and disorders. This initiative has a companion initiative that supports development of devices and diagnostics and is also part of a suite of innovation grants to advance projects to the point where they can meet the entry criteria for the NHLBI Catalyze Preclinical Program.
Key Dates
Posted Date: November 22, 2024
Application Due Date: December 23, 2027
Estimated Award Date: Not Specified
Additional Details
Eligible Applicants
- County governments
- City or township governments
- Native American tribal organizations (other than Federally recognized tribal governments)
- Others
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Public housing authorities/Indian housing authorities
- Special district governments
- State governments
- Native American tribal governments (Federally recognized)
- Independent school districts
- For profit organizations other than small businesses
- Small businesses
- Public and State controlled institutions of higher education
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education